What is the best course of treatment for an adult patient with a history of hypertension or cardiovascular disease experiencing a hypertension crisis?

Hypertensive Crisis Management

Immediate Assessment: Emergency vs. Urgency

The critical first step is determining whether acute target organ damage is present—this distinction, not the blood pressure number itself, dictates whether you have a hypertensive emergency requiring immediate ICU admission with IV therapy, or a hypertensive urgency manageable with oral agents and outpatient follow-up. 1

Define the Crisis Type

• Hypertensive Emergency: BP >180/120 mmHg WITH evidence of new or worsening target organ damage (hypertensive encephalopathy, intracranial hemorrhage, acute MI, acute left ventricular failure, aortic dissection, acute renal failure, eclampsia, advanced retinopathy with hemorrhages/papilledema) 1
• Hypertensive Urgency: BP >180/120 mmHg WITHOUT acute target organ damage—may have non-specific symptoms like headache, palpitations, or malaise 1, 2

Assess for Target Organ Damage Within Minutes

• Neurologic: Altered mental status, severe headache with vomiting, visual disturbances, seizures, focal deficits, loss of consciousness 1
• Cardiac: Chest pain, acute MI (check troponins), acute heart failure with pulmonary edema, ECG changes 1
• Vascular: Signs/symptoms of aortic dissection (tearing chest/back pain, pulse differentials) 1
• Renal: Acute kidney injury (elevated creatinine), oliguria, proteinuria, abnormal urine sediment 1
• Ophthalmologic: Fundoscopy showing hemorrhages, cotton wool spots, papilledema (malignant hypertension) 1, 2

---

Management Algorithm

IF HYPERTENSIVE EMERGENCY (Target Organ Damage Present)

Admit immediately to ICU with continuous arterial line BP monitoring and parenteral antihypertensive therapy. 1

Blood Pressure Reduction Targets

• Standard approach (most emergencies): Reduce mean arterial pressure by 20-25% within the first hour, then if stable reduce to 160/100 mmHg over next 2-6 hours, then cautiously normalize over 24-48 hours 1
• Avoid excessive drops >70 mmHg systolic—this precipitates cerebral, renal, or coronary ischemia, especially in patients with chronic hypertension who have altered autoregulation 1

Specific Condition Targets (Exceptions to Standard Approach)

• Aortic dissection: Reduce SBP to <120 mmHg AND heart rate <60 bpm within 20 minutes using esmolol plus nitroprusside/nitroglycerin 1, 3
• Acute coronary syndrome/pulmonary edema: Reduce SBP to <140 mmHg immediately using nitroglycerin IV 1
• Acute ischemic stroke: Avoid BP reduction unless BP >220/120 mmHg; if exceeds this threshold, reduce MAP by 15% over 1 hour 1
• Acute hemorrhagic stroke: If SBP ≥220 mmHg, carefully lower to 140-160 mmHg within 6 hours to prevent hematoma expansion 1
• Eclampsia/preeclampsia: Use hydralazine, labetalol, or nicardipine (ACE inhibitors, ARBs, and nitroprusside are absolutely contraindicated) 1

First-Line IV Medications

Nicardipine is the preferred agent for most hypertensive emergencies due to predictable titration, rapid onset, and maintenance of cerebral blood flow 1, 4, 5, 6

• Dosing: Start 5 mg/hr IV infusion, titrate by 2.5 mg/hr every 15 minutes to maximum 15 mg/hr 1
• Advantages: Does not increase intracranial pressure, allows careful titration 1
• Caution: May cause reflex tachycardia; avoid in acute heart failure 2

Labetalol is excellent for hypertensive emergencies with renal involvement, cerebrovascular events, or when combined alpha/beta blockade is beneficial 1, 4, 5, 6

• Dosing: 0.25-0.5 mg/kg IV bolus OR 2-4 mg/min continuous infusion until goal BP reached, then 5-20 mg/hr maintenance 1
• Contraindications: Reactive airway disease, COPD, heart block, bradycardia, decompensated heart failure 1

Clevidipine is an alternative first-line agent with ultra-short half-life allowing precise control 1, 4, 5, 6

• Dosing: Start 1-2 mg/hr, double every 90 seconds until BP approaches target, then increase by less than double every 5-10 minutes, maximum 32 mg/hr 1
• Contraindication: Soy/egg allergy, defective lipid metabolism 1

Medications to AVOID

• Sodium nitroprusside: Use only as last resort due to cyanide toxicity risk with prolonged use (>48-72 hours) or renal insufficiency 1, 7, 4, 5, 6
• Immediate-release nifedipine: Causes unpredictable precipitous BP drops and reflex tachycardia that can worsen myocardial ischemia 1, 4, 5, 6
• Hydralazine: Unpredictable response and prolonged duration; not first-line except in eclampsia/preeclampsia 1, 5, 6

Essential Laboratory Tests

• Complete blood count (hemoglobin, platelets) to assess for microangiopathic hemolytic anemia 1
• Basic metabolic panel (creatinine, sodium, potassium) to evaluate renal function 1
• Lactate dehydrogenase (LDH) and haptoglobin to detect hemolysis in thrombotic microangiopathy 1
• Urinalysis for protein and urine sediment examination 1
• Troponins if chest pain present 1
• ECG to assess for cardiac involvement 1

---

IF HYPERTENSIVE URGENCY (No Target Organ Damage)

Do NOT use IV medications—these patients are managed with oral antihypertensives and outpatient follow-up within 1-7 days. 2

Blood Pressure Reduction Target

• Reduce SBP by no more than 25% within first hour, then aim for <160/100 mmHg over next 2-6 hours if stable 1, 2
• Gradually normalize over 24-48 hours 2
• Avoid aggressive inpatient treatment—intensive BP management is not associated with improved outcomes and may increase acute kidney injury, stroke, and myocardial injury 2

First-Line Oral Medications

Captopril (ACE inhibitor) 2

• Must start at very low doses to prevent sudden BP drops in volume-depleted patients (common from pressure natriuresis) 1, 2

Labetalol (combined alpha/beta blocker) 2

• Dual mechanism of action provides effective BP control 2

Extended-release nifedipine (calcium channel blocker) 2

• Use ONLY extended-release formulation 2
• Never use short-acting nifedipine—causes uncontrolled BP falls leading to stroke and death 2, 4, 5, 6

Observation and Follow-up

• Observe for at least 2 hours after initiating oral medication to evaluate BP-lowering efficacy and safety 2
• Approximately one-third of patients with elevated BP normalize before follow-up 2
• Schedule follow-up within 1-7 days; frequent visits (at least monthly) until target BP <130/80 mmHg reached 2

Medications to AVOID in Urgency

• Clonidine: Reserved only for specific situations (cocaine/amphetamine intoxication after benzodiazepines) or last-line when other agents fail; causes significant CNS adverse effects especially in elderly 2
• IV antihypertensives: Reserved exclusively for emergencies with acute target organ damage 2

---

Special Clinical Scenarios

Cocaine/Amphetamine Intoxication

• Initiate benzodiazepines FIRST 1, 2
• If additional BP control needed: phentolamine, nicardipine, or nitroprusside 1, 2
• Avoid beta-blockers (unopposed alpha stimulation) 1

Malignant Hypertension with Renal Failure

• First-line: IV labetalol targeting 20-25% reduction in MAP over several hours 1
• Volume depletion from pressure natriuresis may occur—IV saline may be needed to correct precipitous BP falls 1
• Screen for secondary hypertension (20-40% of cases have secondary causes: renal artery stenosis, pheochromocytoma, primary aldosteronism) 1

Post-Stabilization

• Transition to oral antihypertensive therapy with combination of RAS blockers, calcium channel blockers, and diuretics 1
• Address medication non-compliance—the most common trigger for hypertensive emergencies 1
• Without treatment, hypertensive emergencies carry 1-year mortality >79% and median survival of only 10.4 months 1

---

Critical Pitfalls to Avoid

• Do not treat the BP number alone—the rate of BP rise may be more important than absolute level; patients with chronic hypertension tolerate higher pressures than previously normotensive individuals 1
• Do not reduce BP to normal acutely in most emergencies—altered autoregulation in chronic hypertension means acute normotension causes cerebral, renal, or coronary ischemia 1, 3
• Do not delay laboratory testing—immediate assessment is crucial for appropriate management 1
• Do not use IV medications for hypertensive urgency—21-34% of medical inpatients inappropriately receive IV BP medications despite lack of evidence for benefit 2
• Do not overlook secondary hypertension workup after stabilization—patients remain at high cardiovascular and renal risk 1, 2